NIH #R01CA263575
Novel Therapy to Inhibit IPMN Progression
Active
- Amount
- $600K–$700K
- Period
- 2022-06-08 → 2027-05-31
- PIs
- 2
Awarded at H. LEE MOFFITT CANCER CTR & RES INST
Pancreatic and Hepatic Oncology Research · Oncology
Compare more Oncology professors.
2 total · 1 active
NIH #R01CA263575
Awarded at H. LEE MOFFITT CANCER CTR & RES INST
NIH #R01CA129227
Awarded at H. LEE MOFFITT CANCER CTR & RES INST
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data may not be current
ORCID: 0000-0003-2716-4315